Search Results:
Matching test names:
- D Dimer (See: D-Dimer, Quantitative)
- D pteronyssinus (Mites) (See: Allergen: Inhalants, Environmental Profile 10 - LG5471)
- D. Varnea (Mites) (See: Allergen: Inhalants, Environmental Profile 10 - LG5471)
- D816V (See: Next Generation Sequencing Oncology Tumor Testing)
- D835 (See: FLT3 Mutation Detection ITD/TKD by NGS)
- Dabigatran Level - LG5467
- Dabigatron Level - LG5467
- Darvon (See: Propoxyphene)
- DAT (See: Direct Antiglobulin Test, UMMC-University, Northland, Range and Grand Itasca Only)
- DAT Negative Hemolytic Anemia Workup - LG5612
- DAT/Elution (See: Direct Antiglobulin Test)
- Date Rape Drug (See: Flunitrazepam and Metabolites)
- Date Rape Drug (See: Flunitrazepam Confirmation)
- Datril (See: Acetaminophen to MedTox)
- Daucus Carota, F31 (See: Allergen: Carrot, IgE)
- DAX1 Duplication and Deletion (See: NROB1 Gene Analysis)
- DAX1 Gene Sequencing (See: NROB1 Gene Analysis)
- DCM (See: Cardiomyopathy Gene Analysis)
- DCX (See: Holoprosencephly Gene Evaluation)
- DD (See: D-Dimer, Quantitative)
- dd-cfDNA (See: AlloSure Kidney Transplant Monitoring)
- dd-cfDNA (See: Prospera Transplant Assessment)
- DDD (See: C3G Functional Panel - LG6785)
- D-desoxyephedrine (See: Methamphetamine)
- D-Dimer, Quantitative
- D-Dimer, Quantitative
- Deamidated Gliadin Antibodies, IgA and IgG
- Deamidated Gliadin Peptide Antibodies (See: Deamidated Gliadin Antibodies, IgA and IgG)
- DEB Test (See: Chromosome Analysis, Blood, Fanconi Mutagen Sensitivity Study)
- Decipher Prostate Cancer Classifier - LG6369
- DecodEX Level 2 - LG6520
- Decoy Cells (See: Cytology, Urinary Tract)
- Dehydroepiandrosterone
- Dehydroepiandrosterone Sulfate (See: DHEA Sulfate)
- Deletion and Duplication (See: Osteopetrosis Gene Sequencing)
- Deletion and Duplication (See: Hereditary Hemorrhagic Telangiectasia (ACVR1 and ENG) Sequencing and Deletion/Duplication)
- Deletion and Duplication (See: Holoprosencephly Gene Evaluation)
- Deletion and Duplication (See: PHOX2B Gene Sequencing)
- Deletion and Duplication (See: Hereditary Pressure Palsy Neuropathy)
- Deletion and Duplication (See: Next Generation Sequencing)
- Deletion and Duplication (See: Gaucher Disease Mutation Analysis)
- Deletion and Duplication (See: ALDOB Gene Sequencing)
- Deletion and Duplication (See: Epidermolysis Bullosa Gene Analysis)
- Deletion and Duplication (See: Chronic Granulomatous Gene Analysis)
- Deletion and Duplication (See: Ichthyosis Gene Analysis)
- Delta-Aminolevulinic Acid, Urine (See: Aminolevulinic Acid (ALA), Urine)
- Dementia Auto-Immune Evaluation, CSF - Cancel and reorder as MMMISC - LG6465
- Dementia Auto-Immune Evaluation, CSF - LG6465
- Demerol (See: Meperidine and Normeperidine, Urine)
- Demerol (See: Meperidine and Normeperidine)
- Demyelinating Charcot Marie Tooth (See: Charcot Marie Tooth (CMT) Evaluation)
- Demyelinating Neuropathy Panel - LG5484
- Dengue Fever Antibody, IgG and IgM
- Dentatorubrapallidotuysian Atrophy (See: DRPLA (ATN1) Repeat Expansion DNA Test)
- Deoxycholic Acid (See: Bile Acids, Fractionated and Total)
- Deoxycorticosterone, LC/MS/MS 90973 - LG5323
- Deoxycorticosterone, Pediatric
- Deoxycortisol (See: 11-Deoxycortisol, Quantitative by HPLC-MS/MS, Serum or Plasma)
- Deoxycortisol (See: 11-Deoxycortisol, Pediatric)
- Deoxypyridinoline Crosslinks, Urine
- Depakene (See: Valproic Acid)
- Depakene (See: Valproic Acid, Grand Itasca)
- Depakote (See: Valproic Acid)
- Depakote (See: Valproic Acid, Grand Itasca)
- Derm (See: Dermatopathology)
- Derm Path (See: Dermatopathology)
- Dermatomyositis and Polymyositis Panel
- Dermatomyositis Autoantibody Panel
- Dermatomyositis Panel
- Dermatopathology
- Dermatophyte (See: KOH Skin, Hair or Nails)
- Dermatophyte (See: KOH Skin, Hair or Nails, Range)
- Dermatophyte Culture (See: Fungus Skin, Hair, Nails Culture)
- DES (See: Cardiomyopathy Gene Analysis)
- Desipramine
- Desipramine (See: Drug Screen, Urine, Qualitative)
- Desoxyn (See: Methamphetamine)
- Desyrel (See: Trazodone)
- Dexamethasone Suppresson Test (See: Cortisol)
- Dextromethorphan (See: Drug Screen, Urine, Qualitative)
- Dextromethorphan and Metabolite, Urine
- DFNB4 (See: Pendred Syndrome Gene Sequencing)
- DFNB4 Syndrome (See: Pendred Syndrome Gene Sequencing)
- DGS2 (See: Cardiomyopathy Gene Analysis)
- DHCR7 (See: Holoprosencephly Gene Evaluation)
- DHEA (See: Dehydroepiandrosterone)
- DHEA Sulfate
- DHEA Sulfate, Immunoassay-Pediatric
- DHEA Unconjugated (See: Dehydroepiandrosterone)
- DHEAS (See: DHEA Sulfate)
- DHH (See: Disorders of Sexual Development Gene Analysis)
- DHT (See: 5-a-Dihydrotestosterone)
- Diacetylmorphine (See: Heroin, Confirmation)
- Diagnostic Pap (See: Cytology, Diagnostic Thin Layer Cervical-Vaginal Pap Test With Guided Screening)
- Diagnostic Pap (See: Cytology, Diagnostic Thin Layer Cervical-Vaginal Pap Test (Fairview Range only))
- Diagnostic Pap (See: Cytology, Diagnostic Thin Layer Cervical Vaginal Pap Test, Grand Itasca)
- Dialysis Water Culture
- Diamorphine (See: Heroin, Confirmation)
- Diamox (See: Acetazolamide)
- Diazepam (See: Drug Screen, Urine, Qualitative)
- Diff (See: WBC Count and Differential)
- Differential Leukocyte Count (See: WBC Differential Count)
- Diffuse Large B Cell Lymphoma (DLBCL) NGS Panel
- Diflucan (See: Fluconazole)
- Digibind, Free (See: Digoxin, Free - LG3187)
- Digoxin Level
- Digoxin, Free - LG3187
- Digoxin, Unbound (See: Digoxin, Free - LG3187)
- DIGX (See: Digoxin Level)
- Dihydromorphinone (See: Hydromorphone, GC/MS Confirmation)
- Dihydropryimidine Dehydrogenase (DPYD), 3 Variants - LG5605
- Dihydropteridine Reductase (DHPR) Deficiency
- Dihydropteridine Reductase (DHPR) Deficiency - LG4255
- Dihydrotestosterone Sulfate (See: 5-a-Dihydrotestosterone)
- Dilantin (See: Phenytoin Level, Grand Itasca)
- Dilantin (See: Phenytoin, Free)
- Dilantin (See: Phenytoin Level)
- Dilaudid (See: Hydromorphone, GC/MS Confirmation)
- Diphenhydramine
- Diphenhydramine (See: Drug Screen, Urine, Qualitative)
- Diphenhydramine (Benadryl), Urine
- Diphenylhydantoin (See: Phenytoin Level)
- Diphenylhydantoin (See: Phenytoin Level, Grand Itasca)
- Diphtheria and Tetanus Antibody
- Diphtheria and Tetanus Antibody - Cancel and reorder as ARMISC LG423
- Diphtheria Antibody (See: Diphtheria and Tetanus Antibody - Cancel and reorder as ARMISC LG423)
- Diphtheria Antibody
- Diphtheria Antibody - Cancel and reorder as ARMISC, LG3909
- Diphtheria Culture (See: Corynebacterium diphtheriae Culture)
- Dipropylacetic Acid (See: Valproic Acid, Grand Itasca)
- Dipropylacetic Acid (See: Valproic Acid)
- Direct Antiglobulin Test
- Direct Antiglobulin Test, UMMC-University, Northland and Range Only
- Direct Antiglobulin Test, UMMC-University, Northland, Range and Grand Itasca Only
- Direct Coombs (See: Direct Antiglobulin Test, UMMC-University, Northland, Range and Grand Itasca Only)
- Direct Coombs' Test (See: Direct Antiglobulin Test)
- Direct Dialysis (Triiodothyronine, Free by Equilibrium Dialysis/HPLC-Tandem Mass Spectrometry) (See: Thyroxine, Free by Equilibrium Dialysis)
- Direct EIA (See: RSV Rapid Antigen)
- Direct Immunofluorescent stain/stains DIF - LG6195
- Direct Platelet Antibody (See: Platelet Associated Immunoglobulins, Qualitative)
- Direct Platelet Antibody Screen (See: Platelet Associated Immunoglobulins, Qualitative)
- Direct Platelet Associated Antibody (See: Platelet Associated Immunoglobulins, Qualitative)
- Direct Thrombin Inhibitor Assay (See: Argatroban Assay)
- Disaccharidase, Tissue
- Disopyramide
- Disopyramide Unbound (See: Disopyramide, Free)
- Disopyramide, Free
- Disorders of Sexual Development Gene Analysis
- DISP1 (See: Holoprosencephly Gene Evaluation)
- Diuretic Screen, Urine
- D-Lactate, Plasma
- DLG3 (See: X-Linked Intellectual Disability Gene Analysis)
- DLL1 (See: Holoprosencephly Gene Evaluation)
- DM, Methorphan (See: Dextromethorphan and Metabolite, Urine)
- DM1 DNA Test
- DM2 (CNBP) DNA Test
- DMD (See: Cardiomyopathy Gene Analysis)
- DMP1 Gene Sequencing (See: Hypophosphatemic Rickets Evaluation)
- DMPK DNA Test (See: DM1 DNA Test)
- DNA Antibodies
- DNA BANKING Prevention 500 - LG5651
- DNA Binding (See: DNA Antibodies)
- DNA Cell Cycle Analysis Ploidy and S-Phase - LG761
- DNA Marker Engraftment, Graft vs Host
- DNA Marker Engraftment, Graft vs Host
- DNA Marker, Post BMT Engraftment, Blood
- DNA Marker, Post BMT Engraftment, Blood
- DNA Marker, Post BMT Engraftment, Bone Marrow
- DNA Marker, Post BMT Engraftment, Tissue
- DNA Marker, Pre BMT Engraftment, Recipient Testing
- DNA Marker, Pre BMT Engraftment, Recipient Testing
- DNA Marker, Pre-BMT Engraftment Donor Testing
- DNA Molecular Banking - no longer available
- DNA Polymorphism (See: DNA Marker, Pre-BMT Engraftment Donor Testing)
- DNA Polymorphism (See: DNA Marker, Pre BMT Engraftment, Recipient Testing)
- DNAJC19 (See: Cardiomyopathy Gene Analysis)
- DNase Antibody (See: DNase B Antibodies)
- DNase B Antibodies
- DNMT3A (See: Myelodysplastic Syndrome Focused NGS Panel)
- DOC (See: Deoxycorticosterone, Pediatric)
- DOCK8 Duplication and Deletion (See: Hyper-IgE Syndrome Gene Analysis)
- DOCK8 Gene Sequencing (See: Hyper-IgE Syndrome Gene Analysis)
- DOCK8 Known Mutation (See: Hyper-IgE Syndrome Gene Analysis)
- Dog (See: Allergy Pediatric March Profile IgE)
- Dog Epithelium (See: Allergen: Inhalants, Environmental Profile 10 - LG5471)
- Dolophine (See: Methadone, Serum - LG1451)
- Dominant Charcot-Marie-Tooth (See: Charcot Marie Tooth (CMT) Evaluation)
- Donor Engraftment involved in GVH Disease (See: DNA Marker Engraftment, Graft vs Host)
- Dopamine, Plasma (See: Catecholamines Fractionated, Plasma (Epinephrine, Norepinephrine and Dopamine))
- Double-Stranded DNA Antibodies (See: DNA Antibodies)
- Downs (See: Non-Invasive Prenatal Test Cell Free DNA)
- Downs Syndrome (See: First Trimester Screen Biochemistry Markers)
- Doxepin (See: Drug Screen, Urine, Qualitative)
- Doxepin and Desmethydoxepin
- Doxycycline Level - LG5384
- Doxylamine (See: Drug Screen, Urine, Qualitative)
- DQ*06 (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
- DQ06 (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
- DQB1*06:02 (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
- DQB1-06:02 (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
- DQB1-0602 (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
- DR15 (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
- DR2 (See: HLA Single Antigen Type Allele, Class II, Donor or Recipient)
- DRPLA (ATN1) Repeat Expansion DNA Test
- Drug Abuse (See: Drug Screen, Comprehensive with Reported Medications, Whole Blood)
- Drug Abuse Screen 1, Urine (ER)
- Drug Abuse Screen 1, Urine (ER)
- Drug Abuse Screen 4, Urine (Chem Dep)
- Drug Abuse Screen 4, Urine (Chem Dep)
- Drug Abuse Screen 6, Urine (Chem Dep)
- Drug Abuse Screen 6, Urine (Chem Dep)
- Drug Abuse Screen 7, Urine (Perinatal/Newborn)
- Drug Abuse Screen 7, Urine (Perinatal/Newborn)
- Drug Abuse Screen 77, Urine
- Drug Abuse Screen 8, Urine
- Drug Abuse Screen 8, Urine
- Drug Abuse Screen, Serum
- Drug Abuse Screen, Urine - CUHCC Clinic Only
- Drug Abuse Screen, Urine - CUHCC Clinic Only
- Drug Dependent Platelet Antibody (See: Platelet Antibody, Drug Dependent)
- Drug Detection Panel, Umbilical Cord, Qualitative
- Drug Induced SLE (See: Histone Antibody, IgG)
- Drug Screen (See: Drugs of Abuse Screen, Urine, Grand Itasca)
- Drug Screen (See: Compliance Drug Analysis, Urine)
- Drug Screen 8 with Refllex to Confirmation, Serum - LG6856
- Drug Screen Comprehensive, Serum or Plasma
- Drug Screen, Comprehensive with Reported Medications, Whole Blood
- Drug Screen, Gastric, Qualitative
- Drug Screen, Meconium 10 Panel
- Drug Screen, Meconium 5 Panel
- Drug Screen, Serum/Plasma
- Drug Screen, Urine, Qualitative
- Drug-Dependent RBC Antibody Study - LG5668
- Drugs of Abuse Screen, Urine, Grand Itasca
- Drugs of Abuse Screen, Urine, Point of Care
- DSC2 (See: Cardiomyopathy Gene Analysis)
- DSD (See: Disorders of Sexual Development Gene Analysis)
- dsDNA Antibodies (See: DNA Antibodies)
- DSP (See: Cardiomyopathy Gene Analysis)
- DSP (See: Epidermolysis Bullosa Gene Analysis)
- Dual Genome Panel by Massively Parallel Sequencing
- Duchene Muscular Dystrophy Single Exon Sequencing Known Mutation - LG6118
- Duchenne Muscular Dystrophy, Deletion/Duplication Analysis only - LG5513
- Duchenne Muscular Dystrophy, Female Carrier Testing for Deletion and Duplication - LG5638
- Duchenne Muscular Dystrophy, Stepwise Mutation Deletion Analysis - LG5513
- Duchenne Muscular Dystrophy, Stepwise Mutation Deletion and Sequencing - LG5514
- Duramorph (See: Morphine, Serum or Plasma)
- Dust (See: Allergy Pediatric March Profile IgE)
- Dx XomeDx - Whole Exome Sequencing (Proband) (See: XomeDx to GeneDx - LG6585)
- d-Xylose Absorption Test, Blood (25 g dose) (See: Xylose Absorption Test, Blood & Urine (Adult 25 g dose) - LG4069)
- Dysgenesis (See: Neuropathy Gene Analysis)
- Dysmorphic Erythrocytes, Urine (See: RBC Morphology Evaluation in Urine)
- Dysmorphic RBC, Urine (See: RBC Morphology Evaluation in Urine)
- Dystrophin Gene Direct Sequencing Analysis - LG5646